Jane Street’s Raptor Pharmaceutical RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-14,050
Closed -$75K – 4980
2016
Q2
$75K Buy
+14,050
New +$72K ﹤0.01% 3924
2016
Q1
– Sell
-10,625
Closed -$55K – 5124
2015
Q4
$55K Sell
10,625
-6,459
-38% -$37.5K ﹤0.01% 3866
2015
Q3
$103K Sell
17,084
-208,357
-92% -$2.55M ﹤0.01% 3354
2015
Q2
$3.56M Sell
225,441
-238,370
-51% -$2.9M 0.02% 647
2015
Q1
$5.04M Buy
463,811
+450,828
+3,472% +$4.6M 0.04% 398
2014
Q4
$137K Sell
12,983
-81,953
-86% -$801K ﹤0.01% 2303
2014
Q3
$910K Sell
94,936
-289,968
-75% -$2.96M 0.01% 991
2014
Q2
$4.45M Buy
384,904
+371,664
+2,807% +$3.38M 0.06% 278
2014
Q1
$132K Sell
13,240
-94,418
-88% -$1.36M ﹤0.01% 2469
2013
Q4
$1.4M Sell
107,658
-339,798
-76% -$4.68M 0.02% 611
2013
Q3
$6.68M Buy
447,456
+267,876
+149% +$3.21M 0.08% 184
2013
Q2
$1.68M Buy
+179,580
New +$1.22M 0.03% 542

Other funds holding RPTP

Jane Street's RPTP Position: Q3 2016 in Review

Jane Street sold out of Raptor Pharmaceutical (RPTP) in Q3 2016, closing a stake of 14,050 shares — an estimated $75K sold.

Jane Street first reported a position in RPTP in Q2 2013 and held it in 12 quarters. The position peaked at $6.68M in Q3 2013. 112 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Jane Street reported no remaining Raptor Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • Jane Street sold 14,050 Raptor Pharmaceutical shares in Q3 2016, an estimated $75K.
  • Jane Street first reported a position in Raptor Pharmaceutical in Q2 2013 and held it in 12 quarters.
  • Jane Street's Raptor Pharmaceutical position peaked at $6.68M in Q3 2013.
  • 112 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q3 2016.

Based on Jane Street's 13F filing for Q3 2016, filed 15 Nov 2016.